Skip to content

Validation of SARC-F and Modified SARC-F for Assessing Sarcopenia in Older Adults with Diabetes

Validation of SARC-F and Modified SARC-F for Assessing Sarcopenia in Older Adults with Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20260511010
Enrollment
104
Registered
2026-05-11
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia is characterized by a decline in both muscle quantity and quality, along with impaired function. Sarcopenia can be considered one of the complications associated with diabetes. Poor glycemic control in diabetes can contribute to the development and progression of sarcopenia, leading to muscle mass loss and impaired muscle function. The prevalence of sarcopenia in Type 2 diabetes mellitus (T2DM) varies widely, ranging from 7% to 29.3% across different populations. Diabetic sarcopenia i

Interventions

Sarcopenia will be diagnosed by bioelectrical impedance analysis and hand grip dynamometer,Sarcopenia will be diagnosed by bioelectrical impedance analysis and hand grip dynamometer
Diagnostic,Diagnostic

Sponsors

Department of social medicine Khon Kaen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. older adults with 60 years of age and older 2. diagnosed with type 2 diabetes mellitus

Exclusion criteria

Exclusion criteria: 1. electronic devices or metal materials implanted in the body. 2. neuromuscular disease. 3. unable to comply with follow-up procedures. 4. unwilling or unable to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
Sarcopenia at visit bioelectrical impedance analysis and hand grip dynamometer

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactNatchaphon Tadang

Khon Kaen Hospital

tnatchaphon@gmail.com0868562895

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026